A Phase 1 Study of SKB571 in Subjects With Advanced Solid Tumors

NCT06725381 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

138

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Malignancies

Interventions

DRUG: SKB571

Sponsor

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.